RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Aimmune Therapeutics Stock and on which exchange is it traded?
The symbol for Aimmune Therapeutics is AIMT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Aimmune Therapeutics Stock?
Aimmune Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Aimmune Therapeutics Stock?
Aimmune Therapeutics Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Aimmune Therapeutics Stock.

What's the current price of Aimmune Therapeutics Stock?
As of the end of day on the 2022-05-27, the price of an Aimmune Therapeutics (AIMT) share was $34.49.

What is the 52-week high and low for Aimmune Therapeutics Stock?
The 52-week high for Aimmune Therapeutics Stock is $34.49 and the 52-week low is $34.49.
Click to get the best stock tips daily for free!

About Aimmune Therapeutics

Aimmune Therapeutics Aimmune Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of desensitization treatments for peanut and other food allergies. Its Characterized Oral Desensitization Immunotherapy includes AR101, a product in Phase 3 registration trial for the treatment of peanut allergy in children and adults. The company was formerly known as Allergen Research Corporation and changed its name to Aimmune Therapeutics, Inc. ... AIMT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT